Kjell Rensfeldt
board of director
Moberg Pharma
Sweden
Biography
Kjell Rensfeldt, VP Research and Development, Chief Medical Officer, MD, M.Sc. Econ. Born 1957. Has worked for the company since 2007. Kjell Rensfeldt has ten years' industrial experience of leading positions within Biogen Idec and Q-Med. Dr Rensfeldt also has ten years' clinical experience and has undergone specialist training in urology. Shareholding: 10 000 shares and 100 000 employee stock options (100 000 shares may be subscribed to, based on the stock options).
Research Interest
urology
